126 related articles for article (PubMed ID: 12972525)
1. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States.
Harlan LC; Clegg LX; Trimble EL
J Clin Oncol; 2003 Sep; 21(18):3488-94. PubMed ID: 12972525
[TBL] [Abstract][Full Text] [Related]
2. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
4. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
[TBL] [Abstract][Full Text] [Related]
5. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
6. Insurance status and the use of guideline therapy in the treatment of selected cancers.
Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer: patterns of surgical care across the United States.
Goff BA; Matthews BJ; Wynn M; Muntz HG; Lishner DM; Baldwin LM
Gynecol Oncol; 2006 Nov; 103(2):383-90. PubMed ID: 17005244
[TBL] [Abstract][Full Text] [Related]
9. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
10. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
11. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
12. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer treatment among women of different ethnicity in Hawaii.
Issell BF; Maskarinec G; Pagano I; Gotay CC
Cancer Invest; 2005; 23(6):497-504. PubMed ID: 16203657
[TBL] [Abstract][Full Text] [Related]
14. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity.
Naeim A; Hurria A; Leake B; Maly RC
Crit Rev Oncol Hematol; 2006 Sep; 59(3):234-42. PubMed ID: 16829122
[TBL] [Abstract][Full Text] [Related]
15. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
[TBL] [Abstract][Full Text] [Related]
17. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
[TBL] [Abstract][Full Text] [Related]
18. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
19. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
Freedman RA; He Y; Winer EP; Keating NL
J Clin Oncol; 2009 Feb; 27(5):713-9. PubMed ID: 19103731
[TBL] [Abstract][Full Text] [Related]
20. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]